Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Shares Outstanding (2020 - 2025)

Historic Shares Outstanding for Verastem (VSTM) over the last 6 years, with Q3 2025 value amounting to $66.7 million.

  • Verastem's Shares Outstanding rose 6578.78% to $66.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.7 million, marking a year-over-year increase of 6578.78%. This contributed to the annual value of $44.8 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Verastem's Shares Outstanding is $66.7 million, which was up 6578.78% from $61.5 million recorded in Q2 2025.
  • In the past 5 years, Verastem's Shares Outstanding registered a high of $66.7 million during Q3 2025, and its lowest value of $15.4 million during Q4 2021.
  • In the last 5 years, Verastem's Shares Outstanding had a median value of $25.3 million in 2023 and averaged $32.4 million.
  • In the last 5 years, Verastem's Shares Outstanding crashed by 1556.81% in 2021 and then skyrocketed by 12891.39% in 2025.
  • Verastem's Shares Outstanding (Quarter) stood at $15.4 million in 2021, then rose by 8.23% to $16.7 million in 2022, then soared by 51.18% to $25.3 million in 2023, then skyrocketed by 77.26% to $44.8 million in 2024, then surged by 49.05% to $66.7 million in 2025.
  • Its Shares Outstanding was $66.7 million in Q3 2025, compared to $61.5 million in Q2 2025 and $51.5 million in Q1 2025.